aceDeep Learning-Based Enhancement of Already Diagnostic-Quality MRI for Alzheimer's Disease Classification: Effects on Model Performance and Training Data Requirements
Abstract: Background Deep learning (DL)-based image enhancement is widely used to improve suboptimal medical imaging. Whether it also benefits diagnostic-quality MRI in downstream task performance and data-efficiency remains unclear. Purpose To investigate the impact of DL-based enhancement applied to diagnostic quality structural MRI for Alzheimer's disease (AD) classification. Study type Retrospective. Population A total of 2293 brain MRI scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) were split into…
Hospital Universitari Doctor Peset, València 08 by 19Tarrestnom65. CC BY-SA 4.0 · https://creativecommons.org/licenses/by-sa/4.0
A retrospective study of 2293 ADNI brain MRIs plus 270 external NACC scans tested whether SubtleHD, an FDA-cleared deep learning enhancement tool, could improve downstream Alzheimer's classification when applied to already diagnostic-quality 1.5T T1-weighted images. ResNet34 and DenseNet121 models trained on enhanced images outperformed those trained on standard-of-care images on internal and external tests.
The findings matter because they challenge conventional definitions of image quality by showing extra information usable by machine learning can be extracted from diagnostic-quality scans, improving accuracy and reducing data requirements. Uncertainty remains about generalizability given the retrospective design, evidence level 3 designation, and the sharp drop in absolute performance from internal ADNI to external NACC cohorts.
- 2293 ADNI scans split into training (n=1605), validation (n=229), internal test (n=459) plus 270 NACC scans as external test.
- Each scan was enhanced by SubtleHD (SHD), an FDA-cleared DL-based MR enhancement tool and used to train ResNet34 and DenseNet121 for three-class classification.
- ResNet34 accuracy rose from 85.2% to 88.7% with enhancement; DenseNet121 rose from 90.2% to 92.2%.
- External NACC test showed larger gap: SOC-trained 49.2% accuracy and 0.679 macro-AUC versus SHD-trained 63.0% and 0.819.
Applying FDA-cleared SubtleHD enhancement to already diagnostic-quality T1 MRI improved Alzheimer's disease classification performance and allowed models trained on only 70% of enhanced data to match full-data standard-of-care performance.
The rundown
Researchers took 2293 ADNI 1.5T 3D T1-weighted scans and 270 NACC scans, enhancing each with SubtleHD, then trained ResNet34 and DenseNet121 on standard-of-care versus enhanced images to classify cognitively normal, mild cognitive impairment, or AD.
Internal testing showed significant gains for ResNet34 and directional gains for DenseNet121, while data-efficiency experiments showed 70% of enhanced data matched 100% of standard data, and external NACC testing showed SHD-trained models retained advantage even on unenhanced images with macro-AUC 0.772.
Sources
- Peer-reviewedJournal of Magnetic Resonance Imaging2026-08-13
How should this claim be treated?
The debate